These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. n-3 Polyunsaturated fatty acids for the management of alcoholic liver disease: A critical review. Wang M; Ma LJ; Yang Y; Xiao Z; Wan JB Crit Rev Food Sci Nutr; 2019; 59(sup1):S116-S129. PubMed ID: 30580553 [TBL] [Abstract][Full Text] [Related]
4. Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication. Israelsen M; Kim M; Suvitaival T; Madsen BS; Hansen CD; Torp N; Trost K; Thiele M; Hansen T; Legido-Quigley C; Krag A; JHEP Rep; 2021 Oct; 3(5):100325. PubMed ID: 34401690 [TBL] [Abstract][Full Text] [Related]
5. Modest effect of differential dietary vitamin A intake on the pathogenesis of alcohol-associated liver disease. Ferdouse A; Clugston RD Alcohol Clin Exp Res (Hoboken); 2024 Jun; 48(6):1036-1049. PubMed ID: 38649284 [TBL] [Abstract][Full Text] [Related]
6. The Hepatic Lipidome: A Gateway to Understanding the Pathogenes is of Alcohol-Induced Fatty Liver. Clugston RD; Gao MA; Blaner WS Curr Mol Pharmacol; 2017; 10(3):195-206. PubMed ID: 26278391 [TBL] [Abstract][Full Text] [Related]
7. Alcohol Abstinence Rescues Hepatic Steatosis and Liver Injury Pi A; Jiang K; Ding Q; Lai S; Yang W; Zhu J; Guo R; Fan Y; Chi L; Li S Front Pharmacol; 2021; 12():752148. PubMed ID: 34603062 [No Abstract] [Full Text] [Related]
9. The hepatic BMAL1/AKT/lipogenesis axis protects against alcoholic liver disease in mice via promoting PPARα pathway. Zhang D; Tong X; Nelson BB; Jin E; Sit J; Charney N; Yang M; Omary MB; Yin L Hepatology; 2018 Sep; 68(3):883-896. PubMed ID: 29534306 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Hepatotoxicity by a LXR Inverse Agonist in a Model of Alcoholic Liver Disease. Sengupta M; Griffett K; Flaveny CA; Burris TP ACS Pharmacol Transl Sci; 2018 Sep; 1(1):50-60. PubMed ID: 31696159 [TBL] [Abstract][Full Text] [Related]
11. SNX10 mediates alcohol-induced liver injury and steatosis by regulating the activation of chaperone-mediated autophagy. You Y; Li WZ; Zhang S; Hu B; Li YX; Li HD; Tang HH; Li QW; Guan YY; Liu LX; Bao WL; Shen X J Hepatol; 2018 Jul; 69(1):129-141. PubMed ID: 29452206 [TBL] [Abstract][Full Text] [Related]
12. Liver-specific Nrf2 deficiency accelerates ethanol-induced lethality and hepatic injury in vivo. Sun J; Hong Z; Shao S; Li L; Yang B; Hou Y; Wang H; Xu Y; Zhang Q; Pi J; Fu J Toxicol Appl Pharmacol; 2021 Sep; 426():115617. PubMed ID: 34116071 [TBL] [Abstract][Full Text] [Related]
13. Exposure to chlorpyrifos increases neutral lipid accumulation with accompanying increased de novo lipogenesis and decreased triglyceride secretion in McArdle-RH7777 hepatoma cells. Howell GE; Mulligan C; Young D; Kondakala S Toxicol In Vitro; 2016 Apr; 32():181-9. PubMed ID: 26773343 [TBL] [Abstract][Full Text] [Related]
15. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice. Zhang W; Sun Q; Zhong W; Sun X; Zhou Z Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444 [TBL] [Abstract][Full Text] [Related]
16. Hepatic lipid profiling of deer mice fed ethanol using ¹H and ³¹P NMR spectroscopy: a dose-dependent subchronic study. Fernando H; Bhopale KK; Boor PJ; Ansari GA; Kaphalia BS Toxicol Appl Pharmacol; 2012 Nov; 264(3):361-9. PubMed ID: 22884994 [TBL] [Abstract][Full Text] [Related]
17. Acrolein Is a Pathogenic Mediator of Alcoholic Liver Disease and the Scavenger Hydralazine Is Protective in Mice. Chen WY; Zhang J; Ghare S; Barve S; McClain C; Joshi-Barve S Cell Mol Gastroenterol Hepatol; 2016 Sep; 2(5):685-700. PubMed ID: 28119953 [TBL] [Abstract][Full Text] [Related]
18. Human hepatic lipase overexpression in mice induces hepatic steatosis and obesity through promoting hepatic lipogenesis and white adipose tissue lipolysis and fatty acid uptake. Cedó L; Santos D; Roglans N; Julve J; Pallarès V; Rivas-Urbina A; Llorente-Cortes V; Laguna JC; Blanco-Vaca F; Escolà-Gil JC PLoS One; 2017; 12(12):e0189834. PubMed ID: 29244870 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. Kawano Y; Cohen DE J Gastroenterol; 2013 Apr; 48(4):434-41. PubMed ID: 23397118 [TBL] [Abstract][Full Text] [Related]
20. The role of SHP/REV-ERBα/CYP4A axis in the pathogenesis of alcohol-associated liver disease. Yang Z; Smalling RV; Huang Y; Jiang Y; Kusumanchi P; Bogaert W; Wang L; Delker DA; Skill NJ; Han S; Zhang T; Ma J; Huda N; Liangpunsakul S JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34423788 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]